Performance Assessment of the PMD-200 in Subjects at Neurointensive Care Unit
Performance Assessment of the Physiological Monitor Device (PMD-200), a Novel Pain Monitor, in Subjects at Neurointensive Care Unit (NICU).
Sponsor: Medasense Biometrics Ltd
Terminated
Inability to support study performance
Other terminated trials from Medasense Biometrics Ltd
More terminations from Medasense Biometrics Ltd
Other Anesthesia, General trials with similar outcome
This NA trial investigates Anesthesia, General and is currently terminated or withdrawn. Medasense Biometrics Ltd leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2021 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Jun 2021 [monthly]
Unknown Status NA
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medasense Biometrics Ltd
For direct contact, visit the study record on ClinicalTrials.gov .